Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marwan Fakih

Showing results (21-30 of 200) with videos related to

Pageof 20
Sort By:
Journal of Gastrointestinal Oncology|January 13, 2017
Impressive response to dual <i>BRAF</i> and MEK inhibition in patients with BRAF mutant intrahepatic cholangiocarcinoma-2 case reports and a brief reviewViraj Lavingia, Marwan Fakih
Oncology (Williston Park, N.Y.)|December 21, 2006
Prevention of colorectal cancer: an emerging role for high-dose vitamin D supplementation?Marwan Fakih, Annetre Sunga
Journal of Gastrointestinal Oncology|October 3, 2014
The emerging role of neoadjuvant chemotherapy for rectal cancerPatrick M Boland, Marwan Fakih
Journal of Gastrointestinal Oncology|February 22, 2019
Complete response to pembrolizumab in a patient with metastatic colon cancer with microsatellite instability and a history of Guillain-Barre syndromeChongkai Wang, Jaideep Sandhu, Marwan Fakih
Anticancer Research|December 27, 2011
Single-agent paclitaxel in advanced anal cancer after failure of cisplatin and 5-fluorouracil chemotherapyAli Abbas, Elie Nehme, Marwan Fakih
The Oncologist|May 31, 2022
Mucinous Histology Is Associated with Resistance to Anti-EGFR Therapy in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal CancerChongkai Wang, Jaideep Sandhu, Marwan Fakih
Journal of Gastrointestinal Oncology|January 18, 2020
A case of class 3 <i>MEK1</i> mutated metastatic colorectal cancer with a non-durable tumor marker response to MEK and ERK inhibitorsChongkai Wang, Jaideep Sandhu, Marwan Fakih
Journal of Gastrointestinal Oncology|May 9, 2017
Chemotherapy in patients with hepatobiliary cancers and abnormal hepatic functionJun Gong, May Cho, Marwan Fakih
Journal of the National Comprehensive Cancer Network : JNCCN|February 6, 2020
Clinical Response to T-DM1 in HER2-Amplified, KRAS-Mutated Metastatic Colorectal CancerJaideep Sandhu, Chongkai Wang, Marwan Fakih
Journal of Surgical Oncology|February 26, 2019
Systemic treatment for metastatic colorectal cancer in the era of precision medicineJaideep Sandhu, Viraj Lavingia, Marwan Fakih
Pageof 20

Showing results (21-30 of 200) with videos related to

Sort By:
Pageof 20
Journal of Gastrointestinal Oncology|January 13, 2017
Impressive response to dual <i>BRAF</i> and MEK inhibition in patients with BRAF mutant intrahepatic cholangiocarcinoma-2 case reports and a brief reviewViraj Lavingia, Marwan Fakih
Oncology (Williston Park, N.Y.)|December 21, 2006
Prevention of colorectal cancer: an emerging role for high-dose vitamin D supplementation?Marwan Fakih, Annetre Sunga
Journal of Gastrointestinal Oncology|October 3, 2014
The emerging role of neoadjuvant chemotherapy for rectal cancerPatrick M Boland, Marwan Fakih
Journal of Gastrointestinal Oncology|February 22, 2019
Complete response to pembrolizumab in a patient with metastatic colon cancer with microsatellite instability and a history of Guillain-Barre syndromeChongkai Wang, Jaideep Sandhu, Marwan Fakih
Anticancer Research|December 27, 2011
Single-agent paclitaxel in advanced anal cancer after failure of cisplatin and 5-fluorouracil chemotherapyAli Abbas, Elie Nehme, Marwan Fakih
The Oncologist|May 31, 2022
Mucinous Histology Is Associated with Resistance to Anti-EGFR Therapy in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal CancerChongkai Wang, Jaideep Sandhu, Marwan Fakih
Journal of Gastrointestinal Oncology|January 18, 2020
A case of class 3 <i>MEK1</i> mutated metastatic colorectal cancer with a non-durable tumor marker response to MEK and ERK inhibitorsChongkai Wang, Jaideep Sandhu, Marwan Fakih
Journal of Gastrointestinal Oncology|May 9, 2017
Chemotherapy in patients with hepatobiliary cancers and abnormal hepatic functionJun Gong, May Cho, Marwan Fakih
Journal of the National Comprehensive Cancer Network : JNCCN|February 6, 2020
Clinical Response to T-DM1 in HER2-Amplified, KRAS-Mutated Metastatic Colorectal CancerJaideep Sandhu, Chongkai Wang, Marwan Fakih
Journal of Surgical Oncology|February 26, 2019
Systemic treatment for metastatic colorectal cancer in the era of precision medicineJaideep Sandhu, Viraj Lavingia, Marwan Fakih
Pageof 20